Skip to main content

Leheny A. Rachel's Form 4 filing

CalciMedica, Inc. (CALC) · filed Jun 8, 2023

Accession no.
0001209191-23-035609
Filed
Jun 8, 2023
Trade date
Jun 6-7, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions. Open-market purchases total $10.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Leheny A. RachelCIK 0001484729Director, Officer (Chief Executive Officer), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 6, 2023Common StockPPurchaseAcquired+1,000$5.13F1+$5,1307,000Direct
Jun 7, 2023Common StockPPurchaseAcquired+1,000$5.25F2+$5,2508,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The weighted average purchase price for the transaction reported was $5.1287, and the range of prices were between $4.48 and $5.24. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

F2

The weighted average purchase price for the transaction reported was $5.2478, and the range of prices were between $5.225 and $5.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)